Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own…
Read more Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands dealKimberly-Clark Corp. KMB, +0.01% stock was up by 2.2% in premarket trading on Tuesday after the household products maker said its second-quarter profit fell by 77%, but its…
Read more Kimberly-Clark profit drops by 77% but adjusted earnings and revenue beat estimatesThat’s the practice by many S&P 500 food and consumer companies of raising prices to protect what a new report calls their “cushioned corporate profits,” and it has…
Read more ‘Greedflation’ is replacing inflation as companies raise prices for bigger profits, report finds
